Physician profile
Chit Wong
NPI 1700982170
$1,178.49
in general payments reported to CMS, 2019-2025
17 companies · $17.85 in 2025
The $17.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $173 · 2021: $233 · 2022: $201 · 2023: $97.99 · 2024: $309 · 2025: $17.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418 · Travel and Lodging: $6.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.15 |
| Travel and Lodging | $6.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $359.67 | 2020-2024 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $144.93 | 2019-2025 | Airsupra, Fasenra |
| Abbott Laboratories | $99.00 | 2022-2024 | Freestyle Libre 3 |
| Optinose US, INC. | $91.11 | 2021-2024 | |
| Horizon Therapeutics Plc | $88.67 | 2019-2022 | |
| Novo Nordisk INC | $84.31 | 2019-2022 | |
| Pfizer INC. | $63.20 | 2019-2022 | |
| Astellas Pharma US INC | $49.33 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $41.65 | 2022 | |
| Abiomed | $30.64 | 2023 | Impella |
| Abbvie INC. | $27.11 | 2024 | |
| Eisai INC. | $23.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.95 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $16.02 | 2023 | Rexulti |
| Scilex Pharmaceuticals INC. | $13.85 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $13.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chit Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.